Bg pattern

GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show translation

Introducción

Prospecto: información para el usuario

Glycophos 216 mg/ml concentrado para solución para perfusión

Glicerofosfato de sodio

Lea todo el prospecto detenidamente antes de empezar a usar este medicamento, porque contiene información importante para usted:

  • Conserve este prospecto, ya que puede tener que volver a leerlo.
  • Si tiene alguna duda, consulte a su médico o farmacéutico.
  • Este medicamento se le ha recetado solamente a usted y no debe dárselo a otras personas aunque tengan los mismos síntomas, ya que puede perjudicarles.
  • Si experimenta efectos adversos, consulte a su médico o farmacéutico, incluso si se trata de efectos adversos que no aparecen en este prospecto. Ver sección 4.

Contenido del prospecto:

  1. Qué es Glycophos y para qué se utiliza
  2. Qué necesita saber antes de usar Glycophos
  3. Cómo usar Glycophos
  4. Posibles efectos adversos
  5. Conservación de Glycophos
  6. Contenido del envase e información adicional

1. Qué es Glycophos y para qué se utiliza

Glycophos es un concentrado para solución para perfusión, que pertenece al grupo de medicamentos denominado soluciones electrolíticas, aditivos para soluciones intravenosas.

Glycophos está indicado en pacientes adultos y niños como suplemento en nutrición intravenosa para cubrir las necesidades de fosfato.

Glycophos es un medicamento que le administrará el médico o un profesional sanitario.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Qué necesita saber antes de usar Glycophos

No use Glycophos:

  • si es alérgico (hipersensible) al glicerofosfato sódico o a cualquiera de los demás componentes de este medicamento.
  • si se encuentra en un estado de deshidratación, hipernatremia (niveles altos de sodio en la sangre) o hiperfosfatemia (niveles altos de fosfato en la sangre).
  • si tiene una insuficiencia renal grave o se encuentra en estado de shock.

Advertencias y precauciones

Consulte a su médico antes de empezar a usar este medicamento. Si tiene insuficiencia renal, su médico monitorizará regularmente sus niveles de fosfato en sangre.

Glycophos puede ser añadido o mezclado solamente con otros productos medicinales cuya compatibilidad haya sido documentada.

Glycophos no debe ser administrado sin diluir.

Uso de otros medicamentos:

No se han observado interacciones con otros medicamentos aunque se ha visto una moderada disminución de fosfato sérico durante infusiones de carbohidratos.

Tenga en cuenta que estas instrucciones pueden ser también de aplicación a medicamentos que se hayan tomado antes o puedan tomarse después.

Informe a su médico o farmacéutico si está tomando, ha tomado recientemente o pudiera tener que tomar cualquier otro medicamento, incluso los adquiridos sin receta.

Embarazo y lactancia:

Si está embarazada o en periodo de lactancia, cree que podría estar embarazada o tiene intención de quedarse embarazada, consulte a su médico o farmacéutico antes de utilizar este medicamento.

No hay datos o éstos son limitados relativos al uso de Glycophos en mujeres embarazadas.

Se puede considerar el uso de Glycophos durante el embarazo en aquellos casos en los que esté clínicamente indicado.

Conducción y uso de máquinas:

Se desconoce si Glycophos ejerce efectos conocidos sobre la capacidad para conducir y utilizar máquinas.

3. Cómo usar Glycophos

Siga exactamente las instrucciones de administración de este medicamento indicadas por su médico. En caso de duda, consulte de nuevo a su médico o farmacéutico.

Adultos:

La dosificación recomendada es individual. La dosis diaria recomendada de fosfato durante la nutrición intravenosa es de unos 10 – 20 mmol. Ello puede obtenerse añadiendo 10 – 20 ml de Glycophos a la solución de perfusión o a la mezcla cuya compatibilidad ha sido comprobada.

Niños:

La dosificación recomendada es individual. La dosis recomendada para niños y recién nacidos es 1,0-1,5 mmol/kg de peso corporal/día.

La solución se administrará mediante perfusión intravenosa. Antes de usar comprobar que la solución es homogénea y que el vial no está dañado.

Si usa mas Glycophos del que debiera:

No se han observado efectos adversos causados por una sobredosificación. La mayoría de los pacientes necesitados de nutrición intravenosa tienen un aumento en la capacidad de admitir glicerofosfatos.

En caso de sobredosis o ingestión accidental, consulte con su médico o farmacéutico o llame al Servicio de Información Toxicológica. Teléfono 915 620 420, indicando el medicamento y la cantidad utilizada.

Si tiene cualquier otra duda sobre el uso de este medicamento, pregunte a su médico o farmacéutico.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Posibles efectos adversos

Al igual que todos los medicamentos, Glycophos puede producir efectos adversos, aunque no todas las personas los sufran.

No se han comunicado reacciones adversas relacionadas con glicerofosfatos.

Comunicación de efectos adversos

Si experimenta cualquier tipo de efecto adverso, consulte a su médico o farmacéutico, incluso si se trata de posibles efectos adversos que no aparecen en este prospecto. También puede comunicarlos directamente a través del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano: https://www.notificaram.es. Mediante la comunicación de efectos adversos usted puede contribuir a proporcionar más información sobre la seguridad de este medicamento.

5. Conservación de Glycophos

Mantener fuera de la vista y del alcance de los niños.

Conservar por debajo de 25°C. No congelar.

No utilice Glycophos después de la fecha de caducidad que aparece en el envase después de CAD. La fecha de caducidad es el último día del mes que se indica.

No utilice este medicamento si observa que la solución no es homogénea o el vial está dañado.

Los medicamentos no se deben tirar por los desagües ni a la basura. Pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que no necesita. De esta forma ayudará a proteger el medio ambiente.

6. Contenido del envase e información adicional

Composición de Glycophos

  • El principio activo es glicerofosfato sódico pentahidratado. Un ml de Glycophos contiene 306,1 mg de principio activo (equivalente a 216 mg de glicerofosfato sódico anhidro).
  • Los electrolitos en 1 ml son fosfato (1 mmol) y sodio (2 mmol).
  • Los demás componentes son ácido clorhídrico (para ajustar el pH) y agua para preparaciones inyectables.

Aspecto del producto y contenido del envase

Concentrado para solución para perfusión

Glycophos es una solución transparente, incolora o de color amarillo pálido.

Glycophos está disponible en viales y ampollas de polipropileno.

Los envases contienen 10 viales de 20 ml y 20 ampollas de 20 ml.

Titular de la autorización de comercialización y responsable de la fabricación

Titular de la autorización de comercialización

Fresenius Kabi España S.A.U.

Marina 16-18

08005 Barcelona (España)

Responsable de la fabricación

HP Halden Pharma AS

Svinesundveiem 80

1788 Halden

Noruega

Fecha de la última revisión de este prospecto:Marzo 2020.

Esta información está destinada únicamente a médicos o profesionales del sector sanitario:

Información práctica sobre la preparación y/o manipulación del medicamento

Glycophos no debe ser administrado sin diluir.

Antes de usar, comprobar que la solución es homogénea y que el vial no está dañado.

Compatibilidad

Las adiciones deben realizarse de forma aséptica.

  • 120 ml de Glycophos y 48 mmol de calcio (CaCl2) pueden añadirse a 1000 ml de Vamin Glucosa, Vamin 14, Vamin14 sin electrolitos y Vamin 18 sin electrolitos.
  • 10 ml de Glycophos y 10 mmol de calcio (CaCl2) pueden añadirse a 1000 ml de Glucosa 50 mg/ml.
  • 20 ml de Glycophos y 20 mmol de calcio (CaCl2) pueden añadirse a 1000 ml de Glucosa 200 mg/ml.
  • 60 ml de Glycophos y 24 mmol de calcio (CaCl2) pueden añadirse a 1000 ml de Glucosa 500 mg/ml.

Tiempo de perfusión

El tiempo de perfusión no debe ser inferior a 8 horas

Estabilidad

Cuando se realizan adiciones a una solución para perfusión, la perfusión deberá ser administrada dentro de las 24 horas siguientes a su preparación para prevenir una contaminación microbiana. El contenido sobrante de frascos/viales/ampollas abiertos deberá ser desechado y no podrá guardarse para uso posterior.

Online doctors for GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION

Discuss questions about GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (26)
Doctor

Lina Travkina

Family medicine 13 years exp.

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Camera Book a video appointment
€70
5.0 (4)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (148)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
5.0 (34)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION?
GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION?
The active ingredient in GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION is sodium glycerophosphate. This information helps identify medicines with the same composition but different brand names.
Who manufactures GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION?
GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION is manufactured by Fresenius Kabi España, S.A.U.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION?
Other medicines with the same active substance (sodium glycerophosphate) include POTASSIUM ACETATE B.BRAUN 1 mEq/ml CONCENTRATE FOR INFUSION SOLUTION, SODIUM BICARBONATE 1/6 M MEIN SOLUTION FOR INFUSION, SODIUM BICARBONATE 1M GRIFOLS INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media